Literature DB >> 33730231

Sacrospinous hysteropexy with an autologous rectus fascia sling for treatment of advanced apical pelvic organ prolapse.

Lucas Mira Gon1, Cássio Luís Zanettini Riccetto2, Fábio Coltro Neto2, Arnold Peter Paul Achermann2, Thairo Alves Pereira2, Paulo Cesar Rodrigues Palma2.   

Abstract

INTRODUCTION AND HYPOTHESIS: There is a great interest in avoiding mesh usage in vaginal surgeries. We propose using the autologous rectus fascia to repair apical vaginal prolapse in a similar way it has been successfully used in urinary stress incontinence surgery. This study aims to demonstrate the technique of sacrospinous hysteropexy using autologous rectus fascia for apical pelvic organ prolapse (POP) treatment.
METHODS: We present a video of a 63-year-old female with stage IV pelvic organ prolapse and urinary obstruction. A rectus fascia sling of approximately 90 × 10 mm was harvested through a Pfannenstiel incision. It was used in vaginal surgery to suspend the cervix and fix the apical POP.
RESULTS: The patient resumed her usual activities after 1 week and waited 2 months to resume physical activities and sexual intercourse. She is satisfied at 6 months follow-up, without complications or prolapse recurrence.
CONCLUSION: The sacrospinous hysteropexy using autologous rectus fascia is a feasible technique with excellent results and low risk of complication. Further studies are required to compare POP repair using autologous rectus fascia and polypropylene meshes.
© 2021. The International Urogynecological Association.

Entities:  

Keywords:  Autologous rectus fascia; Pelvic organ prolapse; Sacrospinous hysteropexy

Year:  2021        PMID: 33730231     DOI: 10.1007/s00192-021-04747-5

Source DB:  PubMed          Journal:  Int Urogynecol J        ISSN: 0937-3462            Impact factor:   2.894


  1 in total

1.  Predictors of Clinical Outcome in Women with Pelvic Organ Prolapse Who Underwent Transvaginal Mesh Reconstruction Surgery.

Authors:  Ting-Hsuan Lin; Fung-Chao Tu; Ho-Hsiung Lin; Sheng-Mou Hsiao
Journal:  Medicina (Kaunas)       Date:  2022-01-19       Impact factor: 2.430

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.